People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nevro Corp | — | Biotechnology | Series C | $78.6M | $2.4B | 2010 |
Nick B. Pliam at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nick B. Pliam on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Deedrick | 1 | 7 |
| Vincent Kim | 1 | 4 |
| Michael DeMane | 1 | 4 |
| Konstantinos Alataris | 1 | 3 |
| Andrew Galligan | 1 | 3 |
| Jon Tremmel | 1 | 3 |
| Vince Kim | 1 | 2 |
| Mark B Knudson | 1 | 2 |
| Bill Moffitt | 1 | 1 |
| Nathan Pliam | 1 | 1 |
| Bill Harrington | 1 | 1 |
| Mark Knudson | 1 | 1 |
| Jon B. Tremmel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.